Infectious Disease

Latest News


This 8-year-old boy's mother thought her son had a fungal infection on his feet. Examination disclosed malodorous, nontender plaque formation on the weight-bearing surfaces of both feet. Within the plaques were round pits and furrows.

Although many lacerations are treated in the emergency department, primary care clinicians still see their share of such wounds. Most lacerations are incurred on the face and head (as a result of falls or altercations) or on the hand or lower arm (caused by tools, broken glass, or other sharp objects).

ROCKVILLE, Md. -- Afluria was approved today by the FDA as the sixth seasonal influenza vaccine on the U.S. market. Manufactured by Australia's CSL Limited, the company will produce about two million doses for this year's flu season.

MILWAUKEE -- A Clostridium difficile infection sharply increases the risk of death for patients with underlying inflammatory bowel disease, researchers here said.

SAN FRANCISCO -- In another setback to the effort to create a preventive vaccine against HIV, a key trial has been halted because of a lack of efficacy, according to Merck and the HIV Vaccine Trials Network.

CHICAGO -- Rubella vaccination reduces the risk of Fuchs heterochromic iridocyclitis (FHI), investigators here reported, providing additional support for a link between rubella virus infection and inflammation.

CHICAGO -- A gene that allows micro-organisms to resist the carbapenem antibiotics -- first seen in New York -- is spreading to the Midwest, a St. Louis researcher said here.

BETHESDA, Md. -- The etiology of the rare immune system disorder hyper-IgE syndrome, or Job's syndrome, tracks to mutations in a gene involved in signal transduction and transcription activation, investigators here reported.

CHICAGO -- America's day care centers -- long thought to be a kiddy-pool of pathogens -- are safer than ever thanks to new vaccines, researchers said here.

This MedPage Today video features senior staff writer Michael Smith sitting down with Larry Pickering, M.D., an infectious diseases specialist at the CDC, and Janet Englund, M.D., of the University of Washington in Seattle, to discuss America?s day-care centers and how new vaccines attribute to a safer environment.

CHICAGO -- An antibody that blocks HIV entry to its target T-lymphocytes was found to be well tolerated and effective in the first study to test its activity in humans.

CHICAGO -- When it comes to curing TB quickly, it may be better to be a mouse than a man. Researchers here say a regimen that speeded cures in mice was not much better than standard therapy in people.

LOS ANGELES -- Internet sites that compare surgical care at various hospitals were often inaccessible and frequently displayed inconsistent results, inappropriate quality measures, and out-dated information, researchers reported.